Today, the Honourable Mark Holland, Canada's Minister of Health, and the Honourable John Main, Nunavut's Minister of Health, announced a bilateral agreement investing over $7.3 million over three ...

The facility incorporates best practices and insights from across the company’s manufacturing division network.

In Canada, 1 in 12 people live with a rare disease, and for most people affected, the cost of treatment is unaffordable. Canadians deserve a health care system that provides timely access to quality ...

Patients in England and Wales with a rare genetic disorder will soon be able to access treatment with MSD's Welireg via the NHS, nearly a year after their counterparts in Scotland. In final draft ...

The team are now recruiting patients into a new trial called LITESPARK-022 that combines Keytruda with MSD’s HIF-2 inhibitor Welireg (belzutifan) as an adjuvant treatment for RCC. Welireg was ...

Health Canada has authorized Welireg to treat von Hippel-Lindau (VHL) disease in adults, an inherited genetic condition associated with tumours developing in multiple organs. For the estimated 774 to ...

MSD’s HIV treatment is now back on track after an earlier hit which saw the FDA place a clinical hold on the therapy. Regular readers will know that we love our dividends at Simply Wall St ...

After hours report provides a review of the day’s stock market and treasury market session performance with a recap of indices, sector, and industry performance, trends, as well as key news items that ...

Health care systems that adopted a higher volume of telehealth services less frequently used several low-value screening and diagnostic tests, according to results of a cohort study published in ...

After hours: 12 March at 7:58:13 pm GMT-4 Loading Chart for MRK ...